Warning! GuruFocus detected
1 Medium warning sign
with VETO.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Vetoquinol SA
SIC : 2834
ISIN : FR0004186856
Compare
Compare
Traded in other countries / regions
VETO.France0O1O.UKVETOF.USA8JM.Germany IPO Date
2006-11-16Description
Vetoquinol SA operates is a France-based firm serving in the healthcare market. Its focus lies on developing and marketing veterinary drugs mainly in the European region and to a certain extent in America and Asia. Its portfolio of drugs entails anti-infectives, anti- pain inflammatory drugs, cardiovascular and nephrology treatment intended mainly for pets and livestock.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 11.16 | |||||
| Equity-to-Asset | 0.77 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.14 | |||||
| Interest Coverage | 66.64 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.94 | |||||
| Beneish M-Score | -2.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 7.4 | |||||
| 3-Year EBITDA Growth Rate | 10.8 | |||||
| 3-Year EPS without NRI Growth Rate | 58.5 | |||||
| 3-Year Book Growth Rate | 12.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 2.95 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 2.61 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.76 | |||||
| 9-Day RSI | 50.21 | |||||
| 14-Day RSI | 51.05 | |||||
| 3-1 Month Momentum % | 5.98 | |||||
| 6-1 Month Momentum % | -15.47 | |||||
| 12-1 Month Momentum % | -25.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.76 | |||||
| Quick Ratio | 1.91 | |||||
| Cash Ratio | 1.17 | |||||
| Days Inventory | 244.05 | |||||
| Days Sales Outstanding | 61.96 | |||||
| Days Payable | 193.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.11 | |||||
| Dividend Payout Ratio | 0.22 | |||||
| 3-Year Dividend Growth Rate | 28.2 | |||||
| Forward Dividend Yield % | 1.11 | |||||
| 5-Year Yield-on-Cost % | 2.14 | |||||
| Shareholder Yield % | 1.17 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 68.6 | |||||
| Operating Margin % | 12.08 | |||||
| Net Margin % | 8.77 | |||||
| FCF Margin % | 13.07 | |||||
| ROE % | 8.97 | |||||
| ROA % | 6.91 | |||||
| ROIC % | 10.44 | |||||
| 3-Year ROIIC % | -61.41 | |||||
| ROC (Joel Greenblatt) % | 39.8 | |||||
| ROCE % | 12.75 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 19.25 | |||||
| Forward PE Ratio | 14.78 | |||||
| PE Ratio without NRI | 19.53 | |||||
| Shiller PE Ratio | 22.6 | |||||
| Price-to-Owner-Earnings | 12.93 | |||||
| PEG Ratio | 1.24 | |||||
| PS Ratio | 1.69 | |||||
| PB Ratio | 1.67 | |||||
| Price-to-Tangible-Book | 2.85 | |||||
| Price-to-Free-Cash-Flow | 12.91 | |||||
| Price-to-Operating-Cash-Flow | 10.57 | |||||
| EV-to-EBIT | 10.83 | |||||
| EV-to-EBITDA | 7.44 | |||||
| EV-to-Revenue | 1.42 | |||||
| EV-to-FCF | 10.83 | |||||
| Price-to-GF-Value | 0.73 | |||||
| Price-to-Projected-FCF | 1.1 | |||||
| Price-to-DCF (Earnings Based) | 1.32 | |||||
| Price-to-DCF (FCF Based) | 1.03 | |||||
| Price-to-Median-PS-Value | 0.96 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1 | |||||
| Price-to-Graham-Number | 1.57 | |||||
| Price-to-Net-Current-Asset-Value | 4.13 | |||||
| Earnings Yield (Greenblatt) % | 9.23 | |||||
| FCF Yield % | 7.73 | |||||
| Forward Rate of Return (Yacktman) % | 18.97 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vetoquinol SA Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 537.469 | ||
| EPS (TTM) (€) | 3.99 | ||
| Beta | 0.72 | ||
| 3-Year Sharpe Ratio | -0.57 | ||
| 3-Year Sortino Ratio | -0.69 | ||
| Volatility % | 22.74 | ||
| 14-Day RSI | 51.05 | ||
| 14-Day ATR (€) | 2.527132 | ||
| 20-Day SMA (€) | 78.425 | ||
| 12-1 Month Momentum % | -25.66 | ||
| 52-Week Range (€) | 63.6 - 106 | ||
| Shares Outstanding (Mil) | 11.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vetoquinol SA Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vetoquinol SA Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vetoquinol SA Frequently Asked Questions
What is Vetoquinol SA(XPAR:VETO)'s stock price today?
The current price of XPAR:VETO is €76.80. The 52 week high of XPAR:VETO is €106.00 and 52 week low is €63.60.
When is next earnings date of Vetoquinol SA(XPAR:VETO)?
The next earnings date of Vetoquinol SA(XPAR:VETO) is .
Does Vetoquinol SA(XPAR:VETO) pay dividends? If so, how much?
The Dividend Yield %  of Vetoquinol SA(XPAR:VETO) is 1.11% (As of Today), Highest Dividend Payout Ratio of Vetoquinol SA(XPAR:VETO) was 0.31. The lowest was 0.1. And the median was 0.17. The  Forward Dividend Yield % of Vetoquinol SA(XPAR:VETO) is 1.11%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers